Cargando…
GLP-1 secretion by microglial cells and decreased CNS expression in obesity
BACKGROUND: Type 2 diabetes (T2D) is a strong risk factor for developing neurodegenerative pathologies. T2D patients have a deficiency in the intestinal incretin hormone GLP-1, which has been shown to exert neuroprotective and anti-inflammatory properties in the brain. METHODS: Here we investigate p...
Autores principales: | Kappe, Camilla, Tracy, Linda M, Patrone, Cesare, Iverfeldt, Kerstin, Sjöholm, Åke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546916/ https://www.ncbi.nlm.nih.gov/pubmed/23259618 http://dx.doi.org/10.1186/1742-2094-9-276 |
Ejemplares similares
-
Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats
por: Darsalia, Vladimer, et al.
Publicado: (2012) -
Effects of high-fat diet and the anti-diabetic drug metformin on circulating GLP-1 and the relative number of intestinal L-cells
por: Kappe, Camilla, et al.
Publicado: (2014) -
BLX‐1002 restores glucose sensitivity and enhances insulin secretion stimulated by GLP‐1 and sulfonylurea in type 2 diabetic pancreatic islets
por: Zhang, Qimin, et al.
Publicado: (2014) -
Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization
por: Darsalia, Vladimer, et al.
Publicado: (2014) -
GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals
por: Larsson, Martin, et al.
Publicado: (2019)